LISA BRONAUGH: Open Payments
NPI 1932651700 · EASTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,066 in 42 payments from 14 companies in 2025. Trend: 2023 $970 · 2024 $1,062 · 2025 $1,066
Food & beverage: $1,066
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $311 |
| Lilly USA, LLC | 10 | $202 |
| Sequel Med Tech, LLC | 2 | $103 |
| Abbott Laboratories | 5 | $100 |
| Tandem Diabetes Care, Inc. | 2 | $61 |
| Medtronic, Inc. | 2 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $50 |
| CeQur Corporation | 1 | $50 |
| Radius Health, Inc. | 1 | $28 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
Products named: Ozempic, MOUNJARO, TWIIST, FREESTYLE LIBRE 3, JARDIANCE, t:slim X2 Insulin Pump with Control-IQ, MINIMED 780G, Kerendia.
Industry payments across MD — which companies pay providers there.
